Glis2 is an early effector of polycystin signaling and a target for therapy in polycystic kidney disease.
Zhang C, Rehman M, Tian X, Pei SLC, Gu J, Bell TA 3rd, Dong K, Tham MS, Cai Y, Wei Z, Behrens F, Jetten AM, Zhao H, Lek M, Somlo S.
Zhang C, et al. Among authors: behrens f.
Nat Commun. 2024 May 1;15(1):3698. doi: 10.1038/s41467-024-48025-6.
Nat Commun. 2024.
PMID: 38693102
Free PMC article.